Editas Medicine (EDIT) Gains As Market Dips: What You Should KnowZacks Investment Research • 01/15/21
CRISPR, Editas, Intellia: Gene Editing Stocks To Play The Next Revolution In MedicineForbes • 01/11/21
Editas Medicine Announces the FDA has Cleared Initiation of the EDIT-301 Clinical TrialGlobeNewsWire • 01/11/21
Genetics Stocks Pop After Intellia Offers Update For Gene-Editing DrugsInvestors Business Daily • 01/07/21
Domino's, FedEx, Lockheed, Roku and More of Tuesday Afternoon's Analyst Calls24/7 Wall Street • 01/07/21
Editas Medicine to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/04/21